Clinical Trial Update: Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating suramin with docetaxel or gemcitabine in patients with platinum-refractory stage III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Suramin (suramin)
• Taxotere (docetaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED